Functions of RNA interference in the field of biotechnology include managing pests and diseases caused by bacteria, fungi, and viruses, improving crop yield, and generating plants with novel ...

Big Biotech Biogen is venturing into the city, paying $16 million in cash to partner up with an RNAi company to build ...

BOSTON--(BUSINESS WIRE)--Atalanta Therapeutics, a biotechnology company pioneering ... to address a central limitation for today’s RNAi therapeutics: the difficulty of achieving distribution ...

Yellow biotechnology' refers to biotechnology ... They study gene functions in moth larvae by manipulating genes using the RNA interference technology (RNAi). RNAi is induced by feeding larvae ...

While drugs based on RNAi knockdown technology may have the potential to become the next big thing in biotechnology, they are still a long, long way from becoming FDA-approved marketable entities.

ADARx Pharmaceuticals will work with AbbVie to make RNA interference medicines for a variety of disease areas, including ...

Designing potent silencing triggers is key to the successful application of RNA interference (RNAi) in mammals. Recent studies suggest that the assembly of RNAi effector complexes is coupled to ...

Biogen and City Therapeutics are collaborating to develop select RNAi therapies in a $46 million partnership. City Therapeutics, a private biopharmaceutical company, will offer its RNAi-engineering ...

01. Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Generex Biotechnology Corporation has announced that its Antigen ... trials on a novel immunotherapeutic strategy using the Company's proprietary methods of RNAi stimulation of the immune response ...